Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Risk Factors for Post-ERCP Cholangitis in Patients with Pancreatic Cancer from a Single Referral Center in Iran

  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Cholangitis is relatively uncommon but associated mortality is high due to the predisposition in people with underlying disease. For this recognition of contributing risk factors is necessary. Therefore, the present descriptive-analytical cross-sectional survey was designed to determine contributing risk factors for post-ERCP cholangitis in patients with pancreatic cancer. From 2005 to 2010, 110 consecutive cases of pancreatic cancer attending to a tertiary referral centre (Taleghani Hospital), Tehran, Iran were recruited. The patients all underwent stenting via endoscopic retrograde cholangiopancreatography (ERCP). On univariate analysis, a metallic stent type (95% confidence interval (CI) 1.025-11.34, P=0.037), having no jaundice (1.44-2.22, P=0.009), having no pain (1.32-1.91, P=0.026), a history of prior ERCP (1.16-10.37, P=0.020), and having a proximal biliary stone (1.002-5.93, P=0.046) were related to cholangitis. However on multivariate analysis, none of these factors were found to be contributing risk factors. Cholangitis is avoidable with adequate biliary drainage. Because success rates are higher and complication rates lower for endoscopists performing large volumes of ERCP, performance of the procedure should be concentrated as much as possible in institutions with endoscopists having adequate experience. Patients with a high risk for complications may be best served by referral to an advanced center.

Keywords

References

  1. Boey JH, Way LW (1980). Acute cholangitis. Ann Surg, 191, 264-70. https://doi.org/10.1097/00000658-198003000-00002
  2. Cheng CL, Sherman S, Watkins JL, et al (2006). Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol, 101, 139-47. https://doi.org/10.1111/j.1572-0241.2006.00380.x
  3. Christoforidis E, Goulimaris I, Kanellos I, et al (2002). Post- ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors. Endoscopy, 34, 286-92. https://doi.org/10.1055/s-2002-23630
  4. Freeman ML, DiSario JA, Nelson DB, et al (2001). Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. 54, 425-34. https://doi.org/10.1067/mge.2001.117550
  5. Gerecht WB, Henry NK, Hoffman WW (1989). Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med, 149, 1279-84. https://doi.org/10.1001/archinte.1989.00390060033007
  6. Gigot JF, Leese T, Dereme T, et al (1989). Acute cholangitis. Multivariate analysis of risk factors. Ann Surg, 209, 435-8. https://doi.org/10.1097/00000658-198904000-00008
  7. Lam SK, Wong KP, Chan PK (1978). Recurrent pyogenic cholangitis: a study by endoscopic retrograde cholangiography. Gastroenterology, 74, 1196-203.
  8. Kama NA, Coskun T, Yuksek YN, Yazgan A (1999). Factors affecting post-operative mortality in malignant biliary tract obstruction. Hepatogastroenterology, 46, 103-7.
  9. O'Connor MJ, Schwartz ML, McQuarrie DG, Sumer HW (1982a). Acute bacterial cholangitis: an analysis of clinical manifestation. Arch Surg, 117, 437-41. https://doi.org/10.1001/archsurg.1982.01380280031007
  10. O'Connor MJ, Sumner HW, Schwartz ML (1982b). The clinical and pathologic correlations in mechanical biliary obstruction and acute cholangitis. Ann Surg, 195, 419-23. https://doi.org/10.1097/00000658-198204000-00007
  11. Palazzo L, Girollet PP, Salmeron M (1995). Value of endoscopic ultrasonography in the diagnosis of common bile duct stones: comparison with surgical exploration and ERCP. Gastrointest Endosc, 42, 225-31. https://doi.org/10.1016/S0016-5107(95)70096-X
  12. Vandervoort J, Soetikno RM, Tham TC, et al (2002). Risk factors for complications after performance of ERCP. Gastrointest Endosc, 56, 652-6. https://doi.org/10.1016/S0016-5107(02)70112-0

Cited by

  1. Clinical Efficacy of Endoscopic Pancreatic Drainage for Pain Relief with Malignant Pancreatic Duct Obstruction vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6823
  2. Factors Associated with Diffusely Increased Splenic F-18 FDG Uptake in Patients with Cholangiocarcinoma vol.48, pp.2, 2014, https://doi.org/10.1007/s13139-013-0246-0
  3. Pancreatic cancer: diagnosis and treatments vol.36, pp.3, 2015, https://doi.org/10.1007/s13277-015-3223-7